What Nurses Should Know About the EC Approval of Zolbetuximab Plus Chemotherapy for Advanced Gastric, GEJ Cancer
With the recent European Commission approval of zolbetuximab plus chemotherapy for certain adults with gastric or gastroesophageal junction adenocarcinoma, Cancer Nursing Today spoke with experts about the approval, the data behind it, and what nurses should know about caring for patients receiving this treatment.  ...
Advertisement

Latest News

Advertisement
Advertisement
Our Contributors

Expert Interviews

Conference Highlights

Cecilia BrownBreast Cancer | October 14, 2024
Learn how a team developed a predictive model for breast cancer using cfDNA low-pass whole genome sequencing.
Read More
Cecilia BrownBreast Cancer | October 10, 2024
The study analyzed quality-adjusted time without symptoms of disease progression or toxicity of treatment, known as Q-TWiST.
Amanda Brink, DNP, APRN, FNP-BC, AOCNPTreatment | October 9, 2024
Patients who received the vaccine within 100 days of starting an immune checkpoint inhibitor showed improved survival.
Emilie Plantamura, PharmD, PhDGVHD | October 8, 2024
The ongoing trial is evaluating if MaaT033 can increase survival by preventing complications such as GVHD.

Network Websites